Ignite Creation Date:
2024-05-06 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05128734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-31
First Post:
2021-10-27
Brief Title:
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer TNBC
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Organization Data
Organization:
AHS Cancer Control Alberta
Class:
OTHER
Study ID:
TMZ-TNBC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AHS Cancer Control Alberta
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None